Valuation (9%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -14.08 | 26.26 |
PEG Ratio (TTM) | -2.31 | 9.63 |
P/S Ratio (TTM) | 0.82 | 0.80 |
P/B Ratio (TTM) | 17.72 | 3.30 |
P/FCF Ratio (TTM) | -10.89 | 51.46 |
Price to 5YR AVG Earnings Ratio | N/A | 21.74 |
Price to 5YR AVG FCF Ratio | N/A | 16.67 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -20.82% | 4.33% |
ROE (TTM) | -109.60% | 13.75% |
Net Profit Margin (TTM) | -5.84% | 3.09% |
ROIC 5YR AVG | N/A | 26.49% |
Growth (23%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 2.18% | -141.01% | N/A |
Revenue | 11.75% | 23.76% | N/A |
Net Income | 1.28% | -126.86% | N/A |
Cash Flow | -660.86% | -372.48% | N/A |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.60 | 1.09 |
Quick Ratio (TTM) | 1.60 | 1.07 |
D/E Ratio (TTM) | 1.85 | 0.74 |
Interest Coverage (TTM) | -5.14 | 7.67 |
Piotroski F-Score | 2 | 7 |
Altman Z-Score | 3.50 | 3.18 |
LTL to 5YR AVG FCF | N/A | 3.27 |
Shares Outstanding Growth 5YR AVG | N/A | 0.36% |